International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
复制标题
DOI：
10.1136/thoraxjnl-2015-207488
复制
发表时间：
2016-01-01
期刊：
影响因子：
10
通讯作者：
Elborn, Stuart
中科院分区：
文献类型：
--
作者：
Quittner, Alexandra L.;Abbott, Janice;Elborn, Stuart
测量囊性纤维化（CF）患者心理困扰的研究发现，抑郁和焦虑的发生率很高。CF患者和父母照顾者的心理症状与肺功能下降、体重指数降低、依从性差、健康相关生活质量差、住院次数增加和医疗费用增加相关。为了识别和治疗CF中的抑郁和焦虑，CF基金会和欧洲CF协会邀请了一个专家小组，包括医生，心理学家，精神病学家，护士，社会工作者，药剂师，父母和CF患者，以制定临床护理的共识建议。在18个月的时间里，这个由22名成员组成的委员会被分为四个工作组：筛查;心理干预;药物治疗和实施以及未来研究，并使用人口，干预，比较，结果方法来制定文献检索和审查的问题。研究由达特茅斯的方法学家在PubMed、PsychINFO、ScienceDirect、Google Scholar、Psychiatry online和ABDATA上进行。该委员会审查了344篇文章，起草了声明，并在匿名投票过程之前为每份建议声明设定了80%的接受率作为共识门槛。通过投票最终确定了15项针对CF患者和父母照顾者的抑郁和焦虑筛查和治疗的指南建议声明。由于这些建议在国际上的气候变化中心得到执行，因此应密切监测传播、执行和资源提供的过程，以评估障碍和关切、有效性和使用情况。
Studies measuring psychological distress in individuals with cystic fibrosis (CF) have found high rates of both depression and anxiety. Psychological symptoms in both individuals with CF and parent caregivers have been associated with decreased lung function, lower body mass index, worse adherence, worse health-related quality of life, more frequent hospitalisations and increased healthcare costs. To identify and treat depression and anxiety in CF, the CF Foundation and the European CF Society invited a panel of experts, including physicians, psychologists, psychiatrists, nurses, social workers, a pharmacist, parents and an individual with CF, to develop consensus recommendations for clinical care. Over 18 months, this 22-member committee was divided into four workgroups: Screening; Psychological Interventions; Pharmacological Treatments and Implementation and Future Research, and used the Population, Intervention, Comparison, Outcome methodology to develop questions for literature search and review. Searches were conducted in PubMed, PsychINFO, ScienceDirect, Google Scholar, Psychiatry online and ABDATA by a methodologist at Dartmouth. The committee reviewed 344 articles, drafted statements and set an 80% acceptance for each recommendation statement as a consensus threshold prior to an anonymous voting process. Fifteen guideline recommendation statements for screening and treatment of depression and anxiety in individuals with CF and parent caregivers were finalised by vote. As these recommendations are implemented in CF centres internationally, the process of dissemination, implementation and resource provision should be closely monitored to assess barriers and concerns, validity and use.